Certification figures and their accuracy – (Eye 29, 1516 (November 2015))
Certification figures and their accuracy Eye 29, 1516 (November 2015). doi:10.1038/eye.2015.143 Authors: A Quartilho, A Zekite, W Xing, M Loutfi, C Bunce & R Wormald
The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity – (Eye 29, 1416 (November 2015))
The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity Eye 29, 1416 (November 2015). doi:10.1038/eye.2015.140 Author: D Kent
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population – (Eye 29, 1427 (November 2015))
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population Eye 29, 1427 (November 2015). doi:10.1038/eye.2015.150 Authors: D M Marcus, H Singh, C M Fechter & D P Chamberlain
Stability and safety of MA50 intraocular lens placed in the sulcus – (Eye 29, 1438 (November 2015))
Stability and safety of MA50 intraocular lens placed in the sulcus Eye 29, 1438 (November 2015). doi:10.1038/eye.2015.105 Authors: P S Kemp & T A Oetting
Evaluating digital diabetic retinopathy screening in people aged 90 years and over – (Eye 29, 1442 (November 2015))
Evaluating digital diabetic retinopathy screening in people aged 90 years and over Eye 29, 1442 (November 2015). doi:10.1038/eye.2015.130 Authors: A Tye, H Wharton, A Wright, Y Yang, J Gibson, A Syed, A Mills & P Dodson